Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00829478 · ClinicalTrials.gov registry record · Phase 1
Improving the Quality of Care for Atrial Fibrillation by Promoting Patient-Centered Decision Making
A Phase 1 study, sponsored by VA Connecticut Healthcare System.
- Completed
- Registry status
- Phase 1
- Development phase
- 135
- Enrollment target
NCT00829478: Completed Phase 1 study, sponsored by VA Connecticut Healthcare System.
NCT00829478 is a Phase 1 study that has completed, run by VA Connecticut Healthcare System. The registered enrollment target is 135 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (125% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00829478, a Phase 1 study, has completed, sponsored by VA Connecticut Healthcare System.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 135 participants
- Enrollment target
Study Summary
The primary aim of this proposal is to determine the effectiveness of a decision support tool on improving the process of shared decision-making for treatment on nonvalvular atrial fibrillation (NVAF) compared to receipt of usual care.
Interventions
- OTHER Usual Care
- BEHAVIORAL Decision Aid for Atrial Fibrillation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-06 |
| Phase | Phase 1 |
What the finished NCT00829478 record still lists
NCT00829478 is an interventional study that assigns participants to a tested intervention. The registered 135 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (125% higher).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT00829478 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00829478 about?
NCT00829478 is a clinical study titled "Improving the Quality of Care for Atrial Fibrillation by Promoting Patient-Centered Decision Making". The primary aim of this proposal is to determine the effectiveness of a decision support tool on improving the process of shared decision-making for treatment on nonvalvular atrial fibrillation (NVAF) compared to receipt of usual care.
What is the current status of trial NCT00829478?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 135 participants. The study started on 2008-10. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00829478?
The interventions under investigation include: Usual Care (OTHER), Decision Aid for Atrial Fibrillation (BEHAVIORAL).
Who is sponsoring clinical trial NCT00829478?
This trial is sponsored by VA Connecticut Healthcare System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00829478's enrollment target sits among peer trials
135 425th of 2000 higher than 1,574 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00870129 · 135 participants · NA
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- NCT03666000 · 135 participants · Phase 1
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- NCT04891510 · 135 participants · NA
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
- NCT05121051 · 135 participants · Phase 2
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia